Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06053567 · ClinicalTrials.gov registry record · Phase 3

Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.

A Phase 3 study of Nicotine Dependence, sponsored by Jasper A. Smits.

Recruiting
Registry status
Phase 3
Development phase
360
Enrollment target
1
Study location

NCT06053567 is a Phase 3 study of Nicotine Dependence that is actively recruiting participants, run by Jasper A. Smits. The registered enrollment target is 360 participants, above the 181-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (99% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06053567, a Phase 3 study of Nicotine Dependence, is actively recruiting participants, sponsored by Jasper A. Smits.

RECRUITING
Registry status
Phase 3
Development phase
360 participants
Enrollment target
1
Study location

Study Summary

Anxiety sensitivity, reflecting the fear of bodily sensations, is a risk factor for the maintenance and relapse of smoking. This study is designed to address the question - is a smoking cessation intervention personalized to high anxiety sensitive smokers and adapted for implementation by the YMCA effective among racially/ethnically diverse samples?

Conditions Studied

Interventions

  • BEHAVIORAL Aerobic Exercise
  • BEHAVIORAL Counseling
  • DRUG Nicotine patch

Study Locations (1)

Texas

  • University of Texas at Austin - Austin

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2023-12-27
Est. Completion 2028-06-30
Phase Phase 3

Sponsor

Jasper A. Smits

8 total trials

What the Registry Record Tells You About NCT06053567

The ClinicalTrials.gov registry entry for NCT06053567 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 181-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (99% higher). The listed sponsor is Jasper A. Smits, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 3 interventions - of which Aerobic Exercise is the first listed.

NCT06053567 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06053567 about?

NCT06053567 is a clinical study titled "Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.". Anxiety sensitivity, reflecting the fear of bodily sensations, is a risk factor for the maintenance and relapse of smoking. This study is designed to address the question - is a smoking cessation intervention personalized to high anxiety sensitive smokers and adapted for implementation by the YMCA e...

What is the current status of trial NCT06053567?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 360 participants. The study started on 2023-12-27. Estimated completion is 2028-06-30.

What conditions does trial NCT06053567 study?

This clinical trial studies the following conditions: Nicotine Dependence.

What interventions are being tested in trial NCT06053567?

The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Counseling (BEHAVIORAL), Nicotine patch (DRUG).

Who is sponsoring clinical trial NCT06053567?

This trial is sponsored by Jasper A. Smits, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06053567 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nicotine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.